SciClone Pharmaceuticals, Inc. (SCLN)
$2.59
-0.07 (-2.63%)
| CAPS Rating |
|
|---|---|
| Open | $2.66 |
| Previous Close | $2.66 |
| Daily Range | $2.43 - $2.71 |
| 52-Week Range | $0.63 - $5.33 |
| Market Cap | $122.26M |
| P/E Ratio | 20.46 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 252,381 |
| Average Daily Volume | 360,000 |
SCLN
VS S&P 500 (SPY)
How do you think SCLN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SCLN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SCLN News and Commentary
- UPDATE 1-SciClone Q3 tops estimates, raises '09 view – Reuters
- UPDATE 1-SciClone to cut 17 pct US jobs, take related charge – Reuters
- UPDATE 1-SciClone drops cancer drug development – Reuters
- Build Your Fortune With These Winners – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- Get Ready for the Fall – The Motley Fool
- Difficult Obstacles for SciClone – The Motley Fool
- Not All Pharmaceutical Markets Are the Same – The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
RSS Headlines
Fool UK
